Search
Angioedema Clinical Trials
A listing of 2 Angioedema clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Angioedema
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
There are currently 2 active clinical trials seeking participants for Angioedema research studies. The states with the highest number of trials for Angioedema participants are Ohio, California, Maryland and Michigan.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Recruiting
To assess the efficacy of prophylactic treatment with deucrictibant extended release (XR) tablet versus placebo in preventing angioedema attacks, and to also assess the efficacy of deucrictibant soft capsules as on-demand treatment versus placebo in achieving angioedema symptom relief during acute attacks.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
06/23/2025
Locations: Institute For Asthma & Allergy, Wheaton, Maryland
Conditions: Hereditary Angioedema (HAE), Angioedema, Bradykinin-mediated Angioedema, C1 Inhibitor Deficiency
Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
Recruiting
use of lanadelumab in patients with acquired angioedema
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/24/2025
Locations: Bernstein Clinical Research Center, LLC, Cincinnati, Ohio
Conditions: Angioedema
1 - 2 of 2